Clinical trial
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Prospective Pilot Study to Preliminarily Evaluate the Efficacy of Domperidone in Adult Chinese Subjects With Functional Dyspepsia
NCT03617016 is registered in ClinicalTrials.gov with Xian-Janssen Pharmaceutical Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Prospective Pilot Study to Preliminarily Evaluate the Efficacy of Domperidone in Adult Chinese Subjects With Functional Dyspepsia
- Lead sponsor
- Xian-Janssen Pharmaceutical Ltd.
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- August 27, 2018
- Completion date
- July 31, 2020
- Enrollment
- 160 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.